Lemaitre Vascular (LMAT) Tops Q2 EPS by 16c, Revenue Beat; Offers 3Q EPS/Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
LeMaitre Vascular Announces Q2 2020 Financial Results
July 23, 2020 4:24 PM EDTBURLINGTON, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants and services, today reported Q2 2020 results and announced a $0.095/share quarterly dividend.
Q2 2020 Results
Sales of $24.9mm, -16% (-24% organic) vs. Q2 2019Op. income of $4.9mm, -18%Adjusted op. income of $6.1mm, +3% (excludes acquisition-related special items)Operating margin of 20%Net income of $3.5mm, -24%Earnings of $0.17 per diluted share, -25%EBITDA of $6.4mm, -11%Sales declined... More
